Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
103.1 USD | -0.06% | +0.40% | -5.76% |
04-30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
04-30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.76% | 12.74B | |
+8.02% | 219B | |
+7.74% | 184B | |
+13.11% | 138B | |
-1.37% | 62.54B | |
+4.88% | 52.22B | |
+11.42% | 51.73B | |
+2.38% | 41.4B | |
+5.18% | 37.17B | |
+22.93% | 31.76B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : Revvity, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 09